Max Financial Services Q1 FY27: Margin expansion and AUM milestone set the tone
Ask Iris
Max Financial Services Limited reported a strong start to FY27, supported by growth at Axis Max Life Insurance and a clear step-up in new business profitability. For Q1 FY27 (3M FY27), MFSL reported revenue excluding investment income of INR 7,289 crore, up 18% year on year. The company also reported consolidated profit after tax of INR 118 crore in the investor release.
At the operating company level, Axis Max Life continued to outgrow the private life insurance industry on key new business indicators. Individual adjusted first year premium (FYP) grew 17% year on year to INR 1,810 crore, ahead of private industry growth of 15% in the quarter, while private market share in individual adjusted FYP improved to 10.1%, up 13 basis points.
Growth engine: New business plus a resilient back book
Axis Max Life delivered 15% growth in total APE to INR 1,922 crore in Q1 FY27. Growth was balanced across distribution engines. Proprietary channels grew 15% year on year, supported by 27% growth in online proprietary and 9% growth in offline proprietary. Partnership channels grew 16%, led by 14% growth from Axis Bank and 21% growth from other partnerships. The company also highlighted onboarding of 10 new partners during the quarter.
Importantly, the renewal engine remained strong. Renewal premium grew 20% year on year to INR 4,639 crore, helping gross written premium rise 19% to INR 7,607 crore. Management positioned this as a sign of portfolio resilience, while also pointing to the scale of the franchise, with policies sold up 12% to 187,000.
Financial summary (Q1 FY27)
Product strategy: Protection and annuity lift quality of growth
The quarter again reflected the company’s stated focus on its segments of choice. Retail protection and health APE rose 44% year on year to INR 314 crore, while annuity APE rose 116% to INR 246 crore. Rider APE grew 57% in the quarter, and rider attachment was cited at 39% for Q1 FY27.
The product mix table in the presentation shows the quarter’s APE mix included 10% protection and health, 14% annuity, 12% participating (PAR), 15% non-par savings, 34% group, and 15% ULIP. The line-of-business bridge also shows sharp year on year expansion in annuity and protection and health, alongside a decline in non-par savings.
Management commentary connected these trends to product innovation. The company highlighted two launches in Q1 FY27 that align with targeted customer segments. The Smart Global Investment Fostering Tomorrow Plan (Smart GIFT Plan) was launched as a USD denominated ULIP positioned for the NRI segment. Axis Max Life also launched a variable annuity, Smart Retirement Income with Sustained Earnings Plan (Smart RISE Plan), described as combining guaranteed lifelong income with equity market participation through a transparent NIFTY 50 benchmark. Management also said it launched Aurus, an exclusive proposition for high net worth individuals.
Profitability: VNB growth outpaces APE as margins expand
A key outcome of Q1 FY27 was the expansion in new business margin. Value of new business (VNB) rose 33% year on year to INR 446 crore, while new business margin improved to 23.2% from 20.1% in Q1 FY26. Operating RoEV for the quarter was reported at 14.9%, up 60 basis points year on year, while embedded value rose 15% to INR 30,415 crore as of June 2026.
During the concall, management attributed the margin uplift largely to a combination of product mix and yield curve movement. It stated that, within the approximate 3 percentage point increase, about 30% was linked to protection mix and operating leverage, while about 70% was due to yield curve benefits that also helped offset the GST impact. Management further said most of the GST impact had been addressed earlier, with no additional major effect expected.
Cost efficiency improved on the policyholder expense metric. Policyholder opex to gross written premium improved to 16.0% from 17.8% in the prior year quarter, a reduction of 185 basis points. Management explained that cost actions ranged from productivity improvements in distribution to tighter controls on discretionary spend such as travel and advertising, though it also cautioned that some normalization could occur in later quarters.
Capital, solvency, and structure: Axis infusion completes, refinancing planned
The quarter included a key promoter transaction milestone. Axis Bank infused INR 381 crore into Axis Max Life Insurance for an additional 0.98% stake, taking its shareholding to 19.99%. The company stated this strengthened financial position and supported a solvency ratio of 198% at June 30, 2026.
On capital planning, management said the earlier enabling approval for a QIP at MFSL remains valid until May of the next year, intended to support growth capital requirements. It indicated that the need for capital actions would be assessed against solvency requirements and evolving regulatory developments, including the adoption of Ind AS 117 from April 1, 2027 and the potential introduction of a risk-based capital framework.
Management also clarified sub-debt actions. It confirmed that the call on sub-debt was honored on July 31 and said the company plans to re-raise sub-debt, including recouping the redeemed amount and raising against the additional capacity created by the Axis infusion.
On structure simplification, management reiterated that once a scheme document is filed, the NCLT process typically takes 6 to 12 months, and those timelines still hold. It did not provide a filing date in the call.
Customer and digital platform execution: Trust metrics and AI-led productivity
Axis Max Life continued to emphasize franchise strength through customer metrics and technology adoption. The presentation highlighted an individual death claims paid ratio of 99.8% for FY26 and noted a rank 1 position in customer experience among Indian life insurers in Hansa Research’s syndicated CuES 2026, with an NPS of 61.
Persistency metrics were mixed in the quarter’s disclosures. The persistency slide showed 13th month premium persistency at 83% for 2M FY27 versus 86% for 2M FY26, while longer-tenure metrics improved, such as 37th month premium persistency rising to 67% and 61st month premium persistency rising to 59%. Management said a specific product variant did not perform as expected and impacted persistency.
The company also described digitization and AI as core levers for efficiency and growth. It cited 10 lakh plus customer app installs and 4 lakh monthly active users. The seller platform mSpace was cited with 36,000 monthly active users and over 90% adoption. Management said there are 30 plus AI and ML models in production across recruitment, sales, underwriting, and service, including an AI sales co-pilot supporting 27,000 plus sales interactions.
Takeaways
Q1 FY27 strengthened the investment case narrative around Axis Max Life’s strategy of improving the quality of growth, not just the pace of growth. The quarter combined mid-teens APE expansion with a sharper improvement in VNB and margins, aided by a higher contribution from protection and annuity and supported by yield curve movement.
At the same time, the call highlighted practical execution details investors track closely, including quality-led policy cancellations that affected offline proprietary growth, a persistency impact from a specific product variant, and ongoing capital planning around refinancing and regulatory changes. With AUM crossing INR 2 lakh crore and solvency supported by the Axis infusion, the company enters FY27 with momentum, but with clear sensitivities to yields, regulation, and persistency durability.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
